Chezal JM - Search Results

1

Phase I study of [¹³¹I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.

Thivat E, Rouanet J, Auzeloux P, Sas N, Jouberton E, Levesque S, Billoux T, Mansard S, Molnar I, Chanchou M, Fois G, Maigne L, Chezal JM, Miot-Noirault E, D'Incan M, Durando X, Cachin F. Thivat E, et al. Among authors: chezal jm. BMC Cancer. 2022 Apr 15;22(1):417. doi: 10.1186/s12885-022-09495-3. BMC Cancer. 2022. PMID: 35428211 Free PMC article.

2

Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

Chezal JM, Papon J, Labarre P, Lartigue C, Galmier MJ, Decombat C, Chavignon O, Maublant J, Teulade JC, Madelmont JC, Moins N. Chezal JM, et al. J Med Chem. 2008 Jun 12;51(11):3133-44. doi: 10.1021/jm701424g. Epub 2008 May 16. J Med Chem. 2008. PMID: 18481842

3

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

Desbois N, Gardette M, Papon J, Labarre P, Maisonial A, Auzeloux P, Lartigue C, Bouchon B, Debiton E, Blache Y, Chavignon O, Teulade JC, Maublant J, Madelmont JC, Moins N, Chezal JM. Desbois N, et al. Among authors: chezal jm. Bioorg Med Chem. 2008 Aug 15;16(16):7671-90. doi: 10.1016/j.bmc.2008.07.015. Epub 2008 Jul 10. Bioorg Med Chem. 2008. PMID: 18656367

4

Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent.

Denoyer D, Labarre P, Papon J, Miot-Noirault E, Galmier MJ, Madelmont JC, Chezal JM, Moins N. Denoyer D, et al. Among authors: chezal jm. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Nov 15;875(2):411-8. doi: 10.1016/j.jchromb.2008.09.021. Epub 2008 Sep 25. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18838313

5

Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.

Bonnet-Duquennoy M, Papon J, Mishellany F, Labarre P, Guerquin-Kern JL, Wu TD, Gardette M, Maublant J, Penault-Llorca F, Miot-Noirault E, Cayre A, Madelmont JC, Chezal JM, Moins N. Bonnet-Duquennoy M, et al. Among authors: chezal jm. Int J Cancer. 2009 Aug 1;125(3):708-16. doi: 10.1002/ijc.24413. Int J Cancer. 2009. PMID: 19437532

6

First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracer.

Miot-Noirault E, Gouin F, Vidal A, Rapp M, Maublant J, Askienazy S, Chezal JM, Heymann D, Redini F, Moins N. Miot-Noirault E, et al. Among authors: chezal jm. J Nucl Med. 2009 Sep;50(9):1541-7. doi: 10.2967/jnumed.108.056721. Epub 2009 Aug 18. J Nucl Med. 2009. PMID: 19690026 Free article.

7

The use of [(125)I] scintigraphic in vivo imaging in melanoma-bearing mice for a rapid prescreening of vectors to melanoma tissue.

Miot-Noirault E, Papon J, Gardette M, Bonnet-Duquennoy M, Labarre P, Maisonial A, Madelmont JC, Maublant J, Chezal JM, Moins N. Miot-Noirault E, et al. Among authors: chezal jm. Cancer Biother Radiopharm. 2009 Oct;24(5):629-36. doi: 10.1089/cbr.2008.0608. Cancer Biother Radiopharm. 2009. PMID: 19877894

8

B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator.

Rondepierre F, Bouchon B, Bonnet M, Moins N, Chezal JM, D'Incan M, Degoul F. Rondepierre F, et al. Among authors: chezal jm. Melanoma Res. 2010 Apr;20(2):77-84. doi: 10.1097/CMR.0b013e32833279f2. Melanoma Res. 2010. PMID: 20016392

9

Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.

Miot-Noirault E, Reux B, Debiton E, Madelmont JC, Chezal JM, Coudert P, Weber V. Miot-Noirault E, et al. Among authors: chezal jm. Invest New Drugs. 2011 Jun;29(3):424-33. doi: 10.1007/s10637-009-9371-0. Epub 2009 Dec 23. Invest New Drugs. 2011. PMID: 20033262

10

Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter.

Gardette M, Papon J, Bonnet M, Desbois N, Labarre P, Wu TD, Miot-Noirault E, Madelmont JC, Guerquin-Kern JL, Chezal JM, Moins N. Gardette M, et al. Among authors: chezal jm. Invest New Drugs. 2011 Dec;29(6):1253-63. doi: 10.1007/s10637-010-9471-x. Epub 2010 Jun 22. Invest New Drugs. 2011. PMID: 20567996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters